Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Study Shows Zoono ULTRA GermFree24 Hand Sanitizer Effective Against Human Norovirus Strain

Data Presented at International Association for Food Protection (IAFP) 2018 Annual Meeting Compares Zoono ULTRA GermFree24 Hand Sanitizer to 60 Percent Ethanol Solution


News provided by

Zoono USA

Jul 09, 2018, 10:00 ET

Share this article

Share toX

Share this article

Share toX

SHREWSBURY, N.J., July 9, 2018 /PRNewswire/ -- New data presented today at the International Association for Food Protection (IAFP) 2018 Annual Meeting suggests that ULTRA GermFree24 Hand Sanitizer containing a unique antimicrobial nanotechnology, developed by Zoono USA, is immediately effective against the human norovirus (HuNoV) GII.4 Sydney strain on fingerpad tests, with ongoing, residual efficacy for up to eight hours after application. ULTRA GermFree24 also was significantly more effective than 60 percent ethanol solution, one of three common ingredients in most hand sanitizers. The multi-phased study, "Evaluation of a Hand Sanitizer for Evidence of Residual Activity against Human Norovirus (P1-104)," was presented during Poster Session 1 at the Salt Palace Convention Center in Salt Lake City.

"This study points to the value of innovative hand-sanitizing technology such as ULTRA GermFree24, which provides a long-lasting, defensive barrier against germs even after it dries, for at least up to eight hours," says Thomas French, Chief Executive Officer, Zoono USA.

Norovirus is the leading cause of illness from contaminated food in the U.S. and about 70 percent of these infections are caused by infected food service workers. One in five food service workers have reported working while sick with vomiting and diarrhea.  Approximately 20 million people are sickened by the norovirus each year through close contact with infected people or by eating contaminated food.  Common symptoms of acute gastroenteritis include vomiting, nausea and diarrhea.  Highly contagious, it takes only a few norovirus particles from the hands of an infected food worker to spread infection.  Effective hand hygiene, including hand sanitizers, can help interrupt HuNoV transmission.

"With better hand hygiene not only do we reduce risk of germ exposure, but we also cut down on the transfer of germs," adds Charles Gerba (a.k.a. "Dr. Germ"), microbiologist and professor at the University of Arizona. "Handwashing remains the gold standard; however, when it is not done properly for 15-20 seconds, recontamination continues. Sanitizing technologies help to deliver persistent and residual efficacy that are crucial to killing germs immediately and are an added insurance policy for hands."

About the Study
The multi-phased study assessed the immediate and residual antiviral efficacy of ULTRA GermFree24 against human norovirus. The hand sanitizer was benchmarked against 60 percent ethanol solution. Results were expressed as mean + standard deviation of log10 reduction of human norovirus genome equivalent copies (GEC).

Methodology
Phase I in vitro studies were conducted by suspension assay (ASTM E1052) and in vivo studies using the fingerpad method (ASTM E1838) on human volunteers (n=5). Exposure time was up to 60 seconds. Five to six volunteers were used for phases I, II and III for ULTRA GermFree24. The fingerpad method was modified in Phases II-IV to evaluate residual antiviral activity. Briefly, sanitizer was applied to hands, allowed to dry, and then fingerpads were inoculated with a 20 percent suspension of the epidemic human norovirus GII.4 Sydney strain at five minutes, four hours, or eight hours post-application. All suspension assays were repeated in triplicate. For the fingerpad studies, both hands of the volunteers were used and considered as duplicates.

Statistically Significant Findings

  • In Phase I in vitro assays, ULTRA GermFree24 was more effective than ethanol, producing 2.5±0.02 log GEC versus 0.9±0.04 log GEC reduction, respectively (P<0.05).
  • ULTRA GermFree24 was also more efficacious compared to ethanol in in vivo fingerpad assays (2.8±0.4 log GEC versus 1.7±0.5 log GEC reduction; P<0.05).
  • For Phase II (residual activity of sanitizer post-application), a 1.3±0.4, 0.9±0.3, and 0.7±0.04-log GEC reduction was observed 5 minutes, 4 hours, and 8 hours after product application, respectively. These numbers represented an additional 0.25- to 1.0-log GEC reduction compared to the dry (no product pre-treatment) control.

"Preserving an elevated state of hand hygiene following the removal of gross contamination and rapid bio-load reduction achieved by traditional "instant kill" hand sanitizer technology, such as alcohol, triclosan, or Benzalkonium Chloride (BZK), can also result in reduced infection risk from later contamination events," says Andrew Alexander, Chief Scientific Officer, Zoono USA. "After 99.9 percent of organisms have been killed or inactivated with traditional sanitizer technology, the challenge becomes one of maintenance versus gross log reduction. Continuing to mitigate the presence of microorganisms on human skin long after the sanitizer has dried, in this case continuing to deliver 0.9 and 0.7 log reductions four and eight hours post-application is significant and is evidenced using ULTRA GermFree24."

Full study results available upon request.

About Zoono USA
Zoono USA specializes in the development, manufacture and distribution of a suite of proven, long-lasting, highly effective, and non-toxic antimicrobial solutions based on a unique, antimicrobial nanotechnology that bonds to any surface and kills and inhibits the growth of a broad spectrum of microbial life including: bacteria, viruses, algae, fungi and mold. This technology remains actively antimicrobial for extended periods of time (24 hours on human skin and 30 days on surfaces) making it superior to currently available alternatives. GermFree24 is our line of FDA-compliant personal hygiene products which range from hand sanitizers to acne medication and Microbe Shield is our EPA-registered line of antimicrobial surface products. Zoono USA is committed to providing the best defense against germs on the market with products that are made in the USA and rigorously tested for effectiveness, efficacy, and safety. Zoono is committed to breaking the cycle of infection through persistent efficacy. Your protection is our mission. For more information visit www.zoonousa.com.

MEDIA CONTACT:

Caren Begun
Green Room Communications
201-396-8551
[email protected]

SOURCE Zoono USA

Related Links

https://zoonousa.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.